Efficacy and Safety of Regorafenib with or without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Systematic Review and Arm-Level Synthesis of Real-World Comparative Cohorts.
来源：PubMed发布日期：2026-01-01作者：Yu X, Zan H, Deng W, He R1 次点击